Efficacy of Ustekinumab Treatment Optimization With Two Initial IV Doses in Adults With Severe Crohn's Disease
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Inflammatory Bowel Diseases
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Efficacy of Ustekinumab Optimization by 2 Initial Intravenous Doses in Adult Patients With Severe Crohn's Disease
Inflamm. Bowel Dis. 2024 Aug 01;30(8)1295-1302, H Ren, J Kang, J Wang, J Su, L Zou, A Yin, J Li, Q Zhou, W Wang, Z Tang, J Zhang, Y Lu, Y Yang, C Qiu, Y Ding, W Dong, P AnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.